Bulletin
Investor Alert

Corbus Pharmaceuticals Holdings Inc.

NAS: CRBP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 1, 2021, 7:59 p.m.

/zigman2/quotes/201549545/composite

$

2.43

Change

+0.03 +1.25%

Volume

Volume 71,087

Quotes are delayed by 20 min

/zigman2/quotes/201549545/composite

Previous close

$ 2.18

$ 2.40

Change

+0.22 +10.09%

Day low

Day high

$2.23

$2.46

Open

52 week low

52 week high

$0.91

$9.78

Open

Barbara White

Presently, Barbara White holds the position of Chief Medical Officer at Corbus Pharmaceuticals Holdings, Inc. and Chief Medical Officer for Corbus Pharmaceuticals, Inc. (a subsidiary of Corbus Pharmaceuticals Holdings, Inc.). Dr. White is also on the board of The Johns Hopkins University.

In her past career she was Associate Chief of Staff at Baltimore VA Medical Center, Head-Research & Development at Stiefel Laboratories, Inc., Vice President-Clinical Development at MedImmune LLC and Professor & Vice Chairman-Research Department at the University of Maryland School of Medicine.

Barbara White received a doctorate from Perelman School of Medicine.

Transactions

Date Shares Transaction Value
03/17/2020 15,606   Acquisition at $3.63 per share. 56,649
11/12/2019 3,424   Acquisition at $4.38 per share. 14,997
08/12/2019 1,639   Acquisition at $6.1 per share. 9,997
05/17/2019 1,389   Acquisition at $7.2 per share. 10,000
03/14/2019 4,638   Acquisition at $6.47 per share. 30,007
05/15/2018 2,586   Acquisition at $5.87 per share. 15,179
03/14/2018 2,885   Acquisition at $6.89 per share. 19,877
11/10/2017 2,836   Acquisition at $7 per share. 19,852
08/11/2017 2,479   Acquisition at $6.05 per share. 14,997
05/11/2017 2,435   Acquisition at $6.12 per share. 14,902
03/17/2017 4,233   Acquisition at $9.49 per share. 40,171
11/22/2016 1,000   Acquisition at $7.75 per share. 7,750
08/17/2016 38,000   Acquisition at $3.15 per share. 119,700
06/08/2016 1,935   Acquisition at $3.1 per share. 5,998
06/01/2016 2,570   Acquisition at $3.52 per share. 9,046

Officers and Executives

Dr. Yuval Cohen
Chief Executive Officer & Director
Mr. Sean F. Moran
Chief Financial & Accounting Officer
Dr. Barbara White
Chief Medical Officer
Dr. Sergei Atamas
Executive Director-Research
Mr. Craig Millian
Chief Commercial Officer
Mr. Ross Lobell
Vice President-Regulatory Affairs
Mr. Alan F. Holmer
Chairman
Dr. Peter Salzmann
Independent Director
Mr. Avery W. Catlin
Independent Director
Dr. John Kenneth Jenkins
Independent Director
Ms. Rachelle Jacques
Independent Director
Link to MarketWatch's Slice.